Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects ...
A new blood test that uses artificial intelligence (AI) may offer a faster, more accurate way to determine whether pancreatic cancer treatment is working. Known as ARTEMIS-DELFI, the test detects DNA ...
A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
Healthcare professionals consider a healthy pancreatic elastase level above 200 micrograms per gram (mcg/g). Pancreatic elastase is the digestive enzyme that the pancreas produces to help digest food.
Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Getty Researchers have developed an inexpensive blood test that they say can detect ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four protein biomarkers to better distinguish cancer from noncancerous ...
The blood test achieved high accuracy, with 98% specificity and 73% sensitivity for detecting pancreatic cancer. When combined with CA 19-9 biomarker testing, the sensitivity increased to 85% while ...
Exocrine pancreatic insufficiency (EPI) causes clay-colored, greasy stools that smell foul. A stool test to check for low levels of the elastase enzyme can help diagnose the condition. The pancreas ...
SAN DIEGO--(BUSINESS WIRE)--ClearNote Health, an early cancer detection company focused on enabling people at risk for high-mortality cancers to live longer, healthier lives, today announced the ...
The new test works by detecting two sugars - CA199.STRA and CA19-9 - that are produced by pancreatic cancer cells and escape into the bloodstream. CA19-9 is the current gold-standard biomarker for ...
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a simple blood sample to detect pancreatic cancer at its earliest stages—when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results